Compliance Rate
Compliance Rate
51.23%
Compliant submissions
187
Incompliant submissions
178
Total trials
365
My Organizations' Clinical Trials
Showing 1075 of 2400 entries
View as:
Phase: N/A
Priority: Normal
Start: -
End: -
Due: -
Phase: N/A
Priority: Normal
Start: 08/31/09
End: 04/30/10
Due: 04/30/11
A Phase I Study of Combination Therapy With Didanosine (ddI) and Ribavirin in HIV-Infected Children.
Phase: N/A
Priority: Normal
Start: -
End: 07/31/98
Due: 07/31/99
Phase: N/A
Priority: Normal
Start: 11/30/08
End: 06/30/14
Due: 06/30/15
Phase: N/A
Priority: Normal
Start: 11/30/00
End: 12/31/02
Due: 12/31/03
Phase: N/A
Priority: Normal
Start: 09/23/04
End: 04/06/10
Due: 04/06/11
Phase: N/A
Priority: Normal
Start: -
End: 04/30/14
Due: 04/30/15
Phase: N/A
Priority: Normal
Start: 05/01/20
End: 03/29/21
Due: 03/29/22
Phase: N/A
Priority: Normal
Start: 01/01/24
End: 02/15/24
Due: 02/15/25
Phase: N/A
Priority: Normal
Start: 08/21/02
End: 02/01/08
Due: 02/01/09
Phase: N/A
Priority: Normal
Start: 08/31/09
End: 08/31/12
Due: 08/31/13
Phase: N/A
Priority: Normal
Start: -
End: 07/31/99
Due: 07/31/00
Phase: N/A
Priority: Normal
Start: 05/31/02
End: 08/31/07
Due: 08/31/08
Phase: N/A
Priority: Normal
Start: 11/30/05
End: 11/30/06
Due: 11/30/07
Phase: N/A
Priority: Normal
Start: 04/19/19
End: 12/31/27
Due: 12/31/28
Phase: N/A
Priority: Normal
Start: 01/31/06
End: 12/31/08
Due: 12/31/09
Phase: N/A
Priority: Normal
Start: 10/10/12
End: 08/21/15
Due: 08/21/16
Phase: N/A
Priority: Normal
Start: 08/13/21
End: 03/28/24
Due: 03/28/25
Phase: N/A
Priority: Normal
Start: 11/30/08
End: 07/31/11
Due: 07/31/12
Phase: N/A
Priority: Normal
Start: 09/30/01
End: 11/30/03
Due: 11/30/04
Phase: N/A
Priority: Normal
Start: 12/31/00
End: 11/30/02
Due: 11/30/03
Phase: N/A
Priority: Normal
Start: 10/31/05
End: 03/31/06
Due: 03/31/07
Phase: N/A
Priority: Normal
Start: 10/27/08
End: 12/14/18
Due: 12/14/19
Phase: N/A
Priority: Normal
Start: 03/31/10
End: -
Due: -
Phase: N/A
Priority: Normal
Start: -
End: 06/30/07
Due: 06/30/08